OpenRegistry
Companies House/Birmingham/Company profile

APTAGENIX ONCOLOGY LTD

Active
17223589·incorporated 2026-05-15

APTAGENIX ONCOLOGY LTD is an active UK private limited company, incorporated on 15 May 2026 at Companies House (number 17223589; OpenRegistry canonical ID GB-17223589-aptagenix-oncology-ltd). Sophymarine's OpenRegistry classifies it under SIC 72110 (Research and experimental development on biotechnology), one of 4,267 active UK entities in that code and one of 96,689 active companies registered in Birmingham (postcode B47). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2026-05-15
Registered Address
244 STATION ROAD, WYTHALL, BIRMINGHAM, B47 6ES, UNITED KINGDOM
SIC
72110 — Research and experimental development on biotechnology
Country of origin
United Kingdom

Accounts

Next accounts due 2028-02-15. Financial year-end: 31/05. Filing class: NO ACCOUNTS FILED.

Confirmation statement

Last confirmation statement made up to 2026-05-16. Next confirmation statement due 2027-05-30.

Persons with significant control

APTAGENIX ONCOLOGY LTD has 2 persons with significant control on file:

  • Mr Nicholas David Reid born 1973 resident in United Kingdom, British national. Notified 2026-05-15.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Professor Sarah Shigdar born 1973 resident in Australia, British national. Notified 2026-05-15.
    • Owns 50–75% of shares
    • Holds 50–75% of voting rights
    • Has the right to appoint and remove directors

Previous names

APTAGENIX ONCOLOGY LTD has previously traded as:

  • APTOGENIX ONCOLOGY LTD (until 2026-05-25)

Similar UK companies

Other companies registered under SIC 72110 (Research and experimental development on biotechnology):

Other companies registered in Birmingham: